ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      80.005
      0.00%
      Bitcoin
      103,620.43
      -0.49%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Nymox Pharmaceutical Corp (NYMX) Quote

      Nymox Pharmaceutical Corp

      Nymox Pharmaceutical Corp (NYMX)

      NASDAQ
      0.20
      0.00
      (0.00%)
      Closed January 18 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.20
      Bid
      0.2003
      Ask
      0.2169
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      18.708M
      Previous Close
      0.20
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      93,540,000
      Dividend Yield
      -
      PE Ratio
      -2.12
      Earnings Per Share (EPS)
      -0.09
      Revenue
      -
      Net Profit
      -8.84M

      About Nymox Pharmaceutical Corp

      Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.

      Sector
      Chemicals & Chem Preps, Nec
      Industry
      Chemicals & Chem Preps, Nec
      Website
      www.nymox.com
      Headquarters
      Nassau, Bhs
      Founded
      -

      Ask ADVFN Intelligence (AI)

      NYMX Latest News

      More News

      Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

      August 29 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 13 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      March 28 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 09 2023
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 06 2023
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      October 26 2023
      Edgar (US Regulatory)

      Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

      September 08 2023
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 29 2023
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 02 2023
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      July 31 2023
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      NYMX - Frequently Asked Questions (FAQ)

      What is the current Nymox Pharmaceutical share price?
      The current share price of Nymox Pharmaceutical is $ 0.20
      How many Nymox Pharmaceutical shares are in issue?
      Nymox Pharmaceutical has 93,540,000 shares in issue
      What is the market cap of Nymox Pharmaceutical?
      The market capitalisation of Nymox Pharmaceutical is USD 18.71M
      What is the 1 year trading range for Nymox Pharmaceutical share price?
      Nymox Pharmaceutical has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Nymox Pharmaceutical?
      The price to earnings ratio of Nymox Pharmaceutical is -2.12
      What is the reporting currency for Nymox Pharmaceutical?
      Nymox Pharmaceutical reports financial results in USD
      What is the latest annual profit for Nymox Pharmaceutical?
      The latest annual profit of Nymox Pharmaceutical is USD -8.84M
      What is the registered address of Nymox Pharmaceutical?
      The registered address for Nymox Pharmaceutical is BAY & DEVEAUX STS., 2ND FLOOR, NASSAU, H4M 2V2
      What is the Nymox Pharmaceutical website address?
      The website address for Nymox Pharmaceutical is www.nymox.com
      Which industry sector does Nymox Pharmaceutical operate in?
      Nymox Pharmaceutical operates in the CHEMICALS & CHEM PREPS, NEC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BTCTBTC Digital Ltd
      $ 8.2697
      (73.73%)
      		61.45M
      BDMDBaird Medical Investment Holdings Ltd
      $ 8.80
      (62.36%)
      		18.63M
      CRKNCrown Electrokinetics Corporation
      $ 0.1235
      (54.96%)
      		764.86M
      NUKKNukkleus Inc
      $ 29.97
      (45.98%)
      		19.09M
      GSITGSI Technology
      $ 3.97
      (44.36%)
      		87.7M
      DOGZDogness International Corporation
      $ 18.23
      (-58.77%)
      		740.45k
      ORKTOrangeKloud Technology Inc
      $ 3.02
      (-24.88%)
      		21.08M
      PMAXPowell Max Ltd
      $ 0.6364
      (-23.31%)
      		4.17M
      LGCBLinkage Global Inc
      $ 0.2876
      (-22.27%)
      		890.66k
      YYAIConnexa Sports Technologies Inc
      $ 0.8299
      (-20.20%)
      		602.48k
      CRKNCrown Electrokinetics Corporation
      $ 0.1235
      (54.96%)
      		764.86M
      GCTKGlucoTrack Inc
      $ 0.0852
      (15.45%)
      		465.22M
      RIMEAlgorhythm Holdings Inc
      $ 0.0406
      (-4.02%)
      		387.23M
      TGLTreasure Global Inc
      $ 0.2459
      (14.75%)
      		267.1M
      NVDANVIDIA Corporation
      $ 137.71
      (3.10%)
      		201.4M

      Discussion

      View Full Feed
      AlwaysOptimistic AlwaysOptimistic 3 minutes ago
      I also think there room and enough investors dollars out there for all things tech. Good chance there will be more foreign investment coming in with the change in admins for a more business friendly environment for foreign investment dollars.

      JMO. Please do your own due diligence and
      IONQ
      Dodger1 Dodger1 4 minutes ago
      https:/ /www.juliawalck.com/shop/p/the-most-important-meal-art-print
      AABB
      Dodger1 Dodger1 8 minutes ago
      https ://www.juliawalck.com/shop/p/egg-on-your-face-art-print

      $AABB
      AABB
      TightCoil TightCoil 8 minutes ago
      We have to be wary of a Release with Conditions -
      We must Fight, Fight, Fight For, INSIST ON:

      UNCONDITIONAL RELEASE
      FNMA
      santafe2 santafe2 9 minutes ago
      While all the focus is on tech criminals the real problem may be the crypto Ponzi scheme. They spent reportedly $170MM to get him elected. There's a reason he loves the poorly educated. This is the message heard loud and clear by everyone from banking to investment and, of course, every criminal in
      quester614 quester614 13 minutes ago
      MovyChem was a SCAM company along with Xeriant SRO. MovyChem EU is gone . No website for either. A company that took 20 years to develop Retacell just disappears. I have shown before that Xeriant SRO & MovyChem were started by Vladimír Bíža who can be tracked back to Aegea Inc/ Futureland SCAM He al
      XERI
      3331 3331 14 minutes ago
      BIEL: HUGE HIT IN TAIWAN!
      https://www.actipatchtw.com/general-1
      dinogreeves dinogreeves 16 minutes ago
      Once they kill all the options by the dead line, this will run. Market makers are begging for mercy they don't report before the deadline, they have probably colluded with the insiders too, it is plausible. The quote below is from someone on Stocktwits. Essentially I am not to only one with commo
      SMCI
      Werbe Werbe 18 minutes ago
      Everyone that posts here start with some extraordinary story of upbringing or some sort of passive social shout.  Anyone a high-school dropout or start from welfare?  
      CrypticDomain141 CrypticDomain141 21 minutes ago
      I’ve done my research and I’m long.

      I don’t understand why everyone is so shocked that this is still volatile at this time. It doesn’t have any revenue yet, and it doesn’t have a big pharm partner….yet.

      But from the clinical trials it seems they’ve got the goods. The C
      AVXL
      Drugdoctor Drugdoctor 24 minutes ago
      Here is our CEO's stock chart pattern... Soon we will see $SRNW sporting the same pattern.

      https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
      SRNW
      AlwaysOptimistic AlwaysOptimistic 24 minutes ago
      I also saw that. Of course Chambers would take that position. He has a lot of capital invested in AI and other tech with his venture funding group (JC2 Ventures) and a lot to lose if investors siphon money away from AI in to quantum. Just like NVDIA. This too shall pass IMO.
      IONQ
      SSKILLZ1 SSKILLZ1 25 minutes ago
      Why Pete would play there now is beyond me. Maybe he has a love of public humiliation?

      I have no clue why either. At this point. Which is why I would be shocked if he comes back at this point.

      One thing for sure: any Mets solution at first base that includes regularly p
      4u2nv2 4u2nv2 25 minutes ago
      I have looked at a lot of charts on IFUS. 1M, 1Y, 5Y and I specifically focused on the volume and PPS movement. I did say recently that I am not trading this stock. I do not own any or plan on buying it. I am more focused on a private business model than trading OTC or any stocks. But the IFUS PPS h
      IFUS
      nowwhat2 nowwhat2 25 minutes ago
      Charts are just totally freaking SCREAMING that it COULD be a "Sell The News" Event......and yet ?

      It's like.....



      https://investorshub.advfn.com/uimage/uploads/2025/1/17/zvqmlxrp_!_17_hyper_845pm_CALVIN_INAUG_PARADE_ATH.jpg



      XRPUSD
      littlejohn littlejohn 25 minutes ago
      SMCI will be at 47 to 48 in a Pop

      before we can read the 10K

      filing header...

      That is why you gotta be ready before

      it is filed...

      Around $48 is the recent trading high

      that market makers marked that may
      SMCI
      Drugdoctor Drugdoctor 27 minutes ago
      Remember, assets from other stock mergers will be added to $FORW's holding company. Right now, something is happening with American Blockchain ($GVSI), our CEO's other shell, and if it is the first to merger, some assets will be coming here. Can't wait for $FORW's chart to look like this.
      FORW
      MONTANAJOE MONTANAJOE 27 minutes ago
      Just amuse each other with their nonsense!
      NBRI
      TucsonPhil TucsonPhil 27 minutes ago
      Wow. According to OTC markets, the OS count is now 5,988,649,454. Last time I checked was last year, and I recall it was around 3.9B, when the AS was 5B, then they raised the AS to 10B and have been busy with quite a bit of dilution.
      KGKG
      MONTANAJOE MONTANAJOE 27 minutes ago
      Like it better when they just talk to each other and leave everyone else alone!!
      NBRI
      againstallodds againstallodds 29 minutes ago
      https://investorshub.advfn.com/uimage/uploads/2025/1/17/rarvyIMG_0265.jpeg

      0.5 oz of rhodium per ton of ore can be considered a very high-grade deposit. Here's why:
      * Rhodium is extremely rare: It's one of the rarest and most valuable precious metals.
      * Typical grades
      NBRI
      EarningsCentral EarningsCentral 32 minutes ago
      TLRY
      Drugdoctor Drugdoctor 33 minutes ago
      Who made 300% gains-with-George-Sharp's-$GVSI??>>

      https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
      GVSI
      axelvento axelvento 33 minutes ago
      Moderna is preparing to advance mRNA-1018 into Phase 3. The Company looks forward to sharing the Phase 1/2 results at an upcoming scientific meeting.
      MRNA
      gitreal gitreal 34 minutes ago
      Could it be Mt Vernon assays are flawed, and that the extraordibary Rhodiun assays are skewed ?

      Skewed? No.
      Made up? Yes.
      NBRI

      Your Recent History

      NASDAQ
      NYMX
      Nymox Pharmaceutical
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads